XML 62 R48.htm IDEA: XBRL DOCUMENT v3.20.2
Collaborative Research, Development and License Agreements - Additional Information (Detail)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 29, 2020
USD ($)
Feb. 28, 2019
USD ($)
Feb. 28, 2018
USD ($)
Installment
Dec. 31, 2020
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue recognized         $ 13,414 $ 10,575 $ 27,001 $ 24,649  
Other current liabilities         8,849   8,849   $ 9,987
Intangible assets, net                 2,500
Product                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue recognized         13,276 10,158 26,195 24,086  
Serum Institute of India Pvt. Ltd. | Collaboration Revenue                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue recognized         100 $ 0 800 $ 100  
Reservation Agreement | Coalition for Epidemic Preparedness Innovations                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Deferred revenue         6,300   6,300    
Reservation Agreement | Coalition for Epidemic Preparedness Innovations | Product                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue recognized         0        
Reservation Agreement | Coalition for Epidemic Preparedness Innovations | Forecast                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Revenue recognized       $ 6,300          
Reservation fees       $ 6,300          
Supply Agreement | Valneva SE                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Deferred revenue         14,200   14,200    
Other current liabilities         5,700   5,700    
Grant Agreement | Bill & Melinda Gates Foundation                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Deferred revenue         1,200   1,200    
Grant Agreement | Bill & Melinda Gates Foundation | Maximum                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Proceeds from grant             3,400    
Global Access and Strategy/Commitment Agreement | Bill & Melinda Gates Foundation                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Grants receivable         $ 2,200   $ 2,200    
Sublicense Agreement | Merck, Sharp & Dohme Corp.                  
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]                  
Aggregate amount payable to acquire intangible assets     $ 21,000            
Number of installments | Installment     3            
Payment upon obligation $ 7,000 $ 7,000 $ 7,000            
Agreement expiration month and year     2020-04            
Intangible assets, net                 $ 2,500